[an error occurred while processing this directive]

Home > Newsroom > News Archive

Please note: This article is part of the Cancer Center's News Archive and is here for historical purposes. The information and links may no longer be up-to-date.

Douglas W. Blayney, M.D. named Medical Director

Ann Arbor - Max S. Wicha, M.D., Distinguished Professor of Oncology and Director of the University of Michigan Comprehensive Cancer Center announces the appointment of Douglas W. Blayney, M.D. to the newly-designated post of Medical Director of the Cancer Center.

Blayney, who will also serve as a Clinical Professor of Medicine at the University of Michigan, will be responsible for overseeing clinical services in the more than two dozen cancer care clinics within the Center, and will treat both breast cancer and lymphoma patients. He joins the U-M from a private oncology practice, the Wilshire Oncology Medical Group in Pasadena, California which he joined in 1986 and led since 1992.

“I’m excited to join the team at the University of Michigan and to be part of one of the nation’s top comprehensive cancer centers,” says Blayney. “It’s an unparalleled opportunity to learn from world class people, and for me to help the U-M Comprehensive Cancer Center fulfill its mission of patient care, research and teaching.”

Blayney, a graduate of Stanford University (B.S., 1972) and the University of California at San Diego (UCSD) (M.D.,1977), trained in internal medicine at UCSD and in oncology at the National Cancer Institute in Bethesda, MD. His career has been marked by distinguished volunteer efforts with several prestigious national health care associations, including the American Society of Clinical Oncology (ASCO), where he has served on the Board of Directors as well as the Committees on Clinical Practice, Cancer Education, and Online, and the Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC), where he served from 1999 – 2003.

“We are thrilled to attract a clinician and researcher of Dr. Blayney’s caliber to Michigan,” said Wicha. “With his vast experience as one of the most active clinical investigators in private practice, Doug adds a unique dimension to our staff. He’s a gifted oncologist passionate about both treating patients and exploring a range of scientific questions– from breast cancer and lymphoma research to the application of electronic technologies to enhance the practice of medicine. As we continue to expand the impact U-M has on cancer treatment and research advances nationwide, Dr. Blayney will no doubt make a significant contribution.”

Blayney has authored or co-authored over fifty peer-reviewed articles concerning cancer, cancer therapy and clinical trials, which have been published in scientific periodicals including The New England Journal of Medicine, The Journal of Clinical Oncology, and Blood.

Blayney and his wife and three daughters have settled in Ann Arbor.

The University of Michigan Comprehensive Cancer Center was established in 1986, and soon after was designated a "comprehensive" center by the National Cancer Institute. The comprehensive designation is awarded to centers which achieve the highest standards in patient care, engage in significant prevention and research activities and develop strong community outreach programs. The U-M Cancer Center has more than 200 cancer clinicians and researchers working together in multidisciplinary teams to rapidly bring new prevention, detection and treatment discoveries to patients in its cancer care clinics. This process, called "translational research," is the cornerstone of all cancer care at the University of Michigan, and means U-M patients have access to the highest quality treatment, often before it is available elsewhere.

The Cancer Center sees the most cancer patients of any hospital in the state of Michigan, according to Michigan's Hospital Association. The July 28, 2003 issue of U.S. News & World Report magazine again ranked the University of Michigan Comprehensive Cancer Center among the top 10 cancer centers in the United States.

Contact: Shelley Zalewski (734) 936-9584 for more information.

Return to top

Speak with a Cancer nurse: 1-800-865-1125
[an error occurred while processing this directive]
Please note: The articles listed in the Cancer Center's News Archive are here for historical purposes. The information and links may no longer be up-to-date.
[an error occurred while processing this directive]